InsidersTradesSigma
Follow the Seaport Therapeutics, Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.3bn. The latest transaction was filed on 24 June 2026 (Acquisition). Among the most active insiders: HOMBACH ROBERT J.. Every trade is accessible without an account.
Analysts rate Seaport Therapeutics, Inc. Strong Buy (bullish), based on 5 analysts. Average price target: US$38.00.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Seaport Therapeutics, Inc. 是一家专注于开发创新疗法的公司。它专门从事严重疾病治疗的研发和商业化。